To further validate the prognostic signatures we identified, we first examined the expression levels of CLMP, PLEKHO, and NRP1 in CRC cells (Caco2) and normal colonic mucosal cells (NCM460) using qRT-PCR and Western blotting. This evidence concerns the gene CLMP and colorectal carcinoma.